Recent Finacing
Recent Raise
SphingoTec develops and commercializes biomarker diagnostics (penKid, bio‑ADM) and operates the Nexus IB10 point-of-care immunoassay platform used in ICUs, EDs and hospitals to assess AKI, heart failure and sepsis.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
